iSERA Lifesciences Ltd Financial Ratios
ISERA · Information Technology · Current price ₹143.9
P/E ratio
846.5x
P/B ratio
14.7x
ROE
-8.8%
ROCE
19.1%
Debt / Equity
0.20
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 846.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 14.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -8.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 19.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.20 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with iSERA Lifesciences Ltd's latest numbers.
iSERA Lifesciences Ltd profitability
iSERA Lifesciences Ltd generates a return on equity of -8.8% and a return on capital employed of 19.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.20 and a P/E of 846.5x, iSERA Lifesciences Ltd is conservatively financed. Our overall business-quality score for the company is 4.7 / 10.
Understand the ratios
More on iSERA Lifesciences Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.